Cargando…

Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?

Bone marrow adipose tissue (BMAT) emerges as a distinct fat depot whose importance has been proved in the bone–fat interaction. Indeed, it is well recognized that adipokines and free fatty acids released by adipocytes can directly or indirectly interfere with cells of bone remodeling or hematopoiesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardouin, Pierre, Rharass, Tareck, Lucas, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928601/
https://www.ncbi.nlm.nih.gov/pubmed/27445987
http://dx.doi.org/10.3389/fendo.2016.00085
_version_ 1782440464227500032
author Hardouin, Pierre
Rharass, Tareck
Lucas, Stéphanie
author_facet Hardouin, Pierre
Rharass, Tareck
Lucas, Stéphanie
author_sort Hardouin, Pierre
collection PubMed
description Bone marrow adipose tissue (BMAT) emerges as a distinct fat depot whose importance has been proved in the bone–fat interaction. Indeed, it is well recognized that adipokines and free fatty acids released by adipocytes can directly or indirectly interfere with cells of bone remodeling or hematopoiesis. In pathological states, such as osteoporosis, each of adipose tissues – subcutaneous white adipose tissue (WAT), visceral WAT, brown adipose tissue (BAT), and BMAT – is differently associated with bone mineral density (BMD) variations. However, compared with the other fat depots, BMAT displays striking features that makes it a substantial actor in bone alterations. BMAT quantity is well associated with BMD loss in aging, menopause, and other metabolic conditions, such as anorexia nervosa. Consequently, BMAT is sensed as a relevant marker of a compromised bone integrity. However, analyses of BMAT development in metabolic diseases (obesity and diabetes) are scarce and should be, thus, more systematically addressed to better apprehend the bone modifications in that pathophysiological contexts. Moreover, bone marrow (BM) adipogenesis occurs throughout the whole life at different rates. Following an ordered spatiotemporal expansion, BMAT has turned to be a heterogeneous fat depot whose adipocytes diverge in their phenotype and their response to stimuli according to their location in bone and BM. In vitro, in vivo, and clinical studies point to a detrimental role of BM adipocytes (BMAs) throughout the release of paracrine factors that modulate osteoblast and/or osteoclast formation and function. However, the anatomical dissemination and the difficulties to access BMAs still hamper our understanding of the relative contribution of BMAT secretions compared with those of peripheral adipose tissues. A further characterization of the phenotype and the functional regulation of BMAs are ever more required. Based on currently available data and comparison with other fat tissues, this review addresses the originality of the BMAT with regard to its development, anatomy, metabolic properties, and response to physiological cues.
format Online
Article
Text
id pubmed-4928601
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49286012016-07-21 Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue? Hardouin, Pierre Rharass, Tareck Lucas, Stéphanie Front Endocrinol (Lausanne) Endocrinology Bone marrow adipose tissue (BMAT) emerges as a distinct fat depot whose importance has been proved in the bone–fat interaction. Indeed, it is well recognized that adipokines and free fatty acids released by adipocytes can directly or indirectly interfere with cells of bone remodeling or hematopoiesis. In pathological states, such as osteoporosis, each of adipose tissues – subcutaneous white adipose tissue (WAT), visceral WAT, brown adipose tissue (BAT), and BMAT – is differently associated with bone mineral density (BMD) variations. However, compared with the other fat depots, BMAT displays striking features that makes it a substantial actor in bone alterations. BMAT quantity is well associated with BMD loss in aging, menopause, and other metabolic conditions, such as anorexia nervosa. Consequently, BMAT is sensed as a relevant marker of a compromised bone integrity. However, analyses of BMAT development in metabolic diseases (obesity and diabetes) are scarce and should be, thus, more systematically addressed to better apprehend the bone modifications in that pathophysiological contexts. Moreover, bone marrow (BM) adipogenesis occurs throughout the whole life at different rates. Following an ordered spatiotemporal expansion, BMAT has turned to be a heterogeneous fat depot whose adipocytes diverge in their phenotype and their response to stimuli according to their location in bone and BM. In vitro, in vivo, and clinical studies point to a detrimental role of BM adipocytes (BMAs) throughout the release of paracrine factors that modulate osteoblast and/or osteoclast formation and function. However, the anatomical dissemination and the difficulties to access BMAs still hamper our understanding of the relative contribution of BMAT secretions compared with those of peripheral adipose tissues. A further characterization of the phenotype and the functional regulation of BMAs are ever more required. Based on currently available data and comparison with other fat tissues, this review addresses the originality of the BMAT with regard to its development, anatomy, metabolic properties, and response to physiological cues. Frontiers Media S.A. 2016-06-30 /pmc/articles/PMC4928601/ /pubmed/27445987 http://dx.doi.org/10.3389/fendo.2016.00085 Text en Copyright © 2016 Hardouin, Rharass and Lucas. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Hardouin, Pierre
Rharass, Tareck
Lucas, Stéphanie
Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title_full Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title_fullStr Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title_full_unstemmed Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title_short Bone Marrow Adipose Tissue: To Be or Not To Be a Typical Adipose Tissue?
title_sort bone marrow adipose tissue: to be or not to be a typical adipose tissue?
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928601/
https://www.ncbi.nlm.nih.gov/pubmed/27445987
http://dx.doi.org/10.3389/fendo.2016.00085
work_keys_str_mv AT hardouinpierre bonemarrowadiposetissuetobeornottobeatypicaladiposetissue
AT rharasstareck bonemarrowadiposetissuetobeornottobeatypicaladiposetissue
AT lucasstephanie bonemarrowadiposetissuetobeornottobeatypicaladiposetissue